Article
Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 May 2026
Odintsov Igor, Siegmund Stephanie E, Pecci Federica, Ricciuti Biagio, LoPiccolo Jaclyn, Sands Jacob M, Wang Charlotte I, Sholl Lynette M, Dong Fei
Abstract excerpt
Lung squamous cell carcinoma (LUSC) is the second most common subtype of non-small cell lung carcinoma (NSCLC), typically associated with a poor prognosis. Unlike lung adenocarcinoma, the application of next-generation sequencing (NGS) in LUSC has lagged because of the long-standing perception of low therapeutic yield, primarily based on highly selected, resected cohorts. We sought to determine the real-world...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
